References
- Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) [homepage on the Internet]2015 Available from: http://www.ginasthma.org/Accessed January 19, 2017
- JuniperEFO’ByrnePMGuyattGHFerriePJKingDRDevelopment and validation of a questionnaire to measure asthma controlEur Respir J199914490290710573240
- JuniperEFBousquetJAbetzLBateman ED; CommitteeGOALIdentifying ‘well-controlled’ and ‘not well-controlled’ asthma using the Asthma Control QuestionnaireRespir Med2006100461662116226443
- JuniperEFSvenssonKMörkA-CStåhlEMeasurement properties and interpretation of three shortened versions of the asthma control questionnaireRespir Med200599555355815823451
- BatemanEDBousheyHABousquetJCan guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL studyAm J Respir Crit Care Med2004170883684415256389
- O’ByrnePMNayaIPKallenAPostmaDSBarnesPJIncreasing doses of inhaled corticosteroids compared to adding long-acting inhaled beta2-agonists in achieving asthma controlChest200813461192119918689590
- AdamsNPJonesPWThe dose-response characteristics of inhaled corticosteroids when used to treat asthma: an overview of Cochrane systematic reviewsRespir Med200610081297130616806876
- BatemanEDCheungDLapa e SilvaJGohringUMSchaferMEngelstatterRRandomized comparison of ciclesonide 160 and 640 microg/day in severe asthmaPulm Pharmacol Ther200821348949818178494
- O’ConnorBJKilfeatherSCheungDEfficacy and safety of ciclesonide in patients with severe asthma: a 12-week, double-blind, randomized, parallel-group study with long-term (1-year) follow-upExpert Opin Pharmacother201011172791280320958119
- O’ByrnePMPedersenSMeasuring efficacy and safety of different inhaled corticosteroid preparationsJ Allergy Clin Immunol19981026 pt 18798869847425
- PauwelsRALofdahlCGPostmaDSEffect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study GroupN Engl J Med199733720140514119358137
- BatemanEDEfficacy and safety of high-dose ciclesonide for the treatment of severe asthmaExpert Rev Respir Med20137433934823964625
- TomlinsonJEMcMahonADChaudhuriRThompsonJMWoodSFThomsonNCEfficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthmaThorax200560428228715790982
- LeeDKFardonTCBatesCEHaggartKMcFarlaneLCLipworthBJAirway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthmaChest2005127385186015764767
- MarczakJCiebiadaMGorskiPSwitching from systemic steroids to ciclesonide restores the hypothalamic pituitary-adrenal axisPostepy Dermatol Alergol2014312596425097469
- SzeflerSRohatagiSWilliamsJLloydMKunduSBanerjiDCiclesonide, a novel inhaled steroid, does not affect hypothalamic-pituitary-adrenal axis function in patients with moderate-to-severe persistent asthmaChest200512831104111416162694
- NaveRMuellerHFrom inhaler to lung: clinical implications of the formulations of ciclesonide and other inhaled corticosteroidsInt J Gen Med201369910723516175